Microtubule target for new antileishmanial drugs based on ethyl 3-haloacetamidobenzoates

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 21, Issue 3, 2006, Pages 305-312

  Hiam, Abdala ^a   Sebastien, David ^b   George, Bekesi ^c   Arlette, Fellous ^b   Kalil, Jorge ^d   Le Pape, Patrice ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b Laboratory of Pharmacology   (France)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antileishmanials; Benzoylureas; Cytotoxicity; Ethyl 3 haloacetamidobenzoates; Leishmania; Microtubule

Indexed keywords

(3 HALOACETAMIDOBENZOYL)UREA DERIVATIVE; 3 CHLOROACETAMIDOBENZOIC ACID ETHYL ESTER; 3 HALOACETAMIDOBENZOIC ACID ETHYL ESTER; ANTILEISHMANIAL AGENT; ANTIPROTOZOAL AGENT; CYTOTOXIC AGENT; MEGLUMINE ANTIMONATE; MF 191; MF 29; MF 56; MF 569; MF 708; MICROTUBULE ASSOCIATED PROTEIN 2; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; FETUS; FLUOROMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA INFANTUM; LEISHMANIA MEXICANA; LEISHMANIASIS; MALE; MICROTUBULE ASSEMBLY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; SCANNING ELECTRON MICROSCOPY; STUDENT T TEST;

ACETANILIDES; ANIMALS; ANTIPROTOZOAL AGENTS; BRAIN; CELL LINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOHISTOCHEMISTRY; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIASIS; LIVER; LYMPH NODES; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; MICROTUBULES; PARASITIC SENSITIVITY TESTS; RATS; SENSITIVITY AND SPECIFICITY; SPLEEN;

LEISHMANIA MEXICANA; MAMMALIA; PROTOZOA;

EID: 33746126507     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360600700699     Document Type: Article

References (31)

1. Berman, JD. (1997) Clin Infect Dis, 24, pp. 684-703.
2. Khaw, M and Panosian, CB. (1995) Clin Microbiol Rev, 8, pp. 427-439.
3. Robert, ND and Croft, SL. (1993) Trans Roy Soc Trop Med H, 87, pp. 130.
4. Fong, D and Chang, K. (1981) Proc Natl Acad Sci USA, 78, pp. 7624-7628.
5. Chan, M and Fong, O. (1990) Science, 249, pp. 924-926.
6. Moulay, L and Robert-Gero, M and Brown, S and Gendron, M and Tournier, F. (1996) Exp Cell Res, 226, pp. 283-291.
7. Russell, D and Dubremetz, J. (1986) Parasitol Today, 2, pp. 177-179.
8. Katiyar, S and Gordon, V and Mc Laughlin, G and Edlind, T. (1994) Antimicrob Agents Chemother, 38, pp. 2086-2090.
9. Jiang, JD and Roboz, J and Weisz, I and Deng, L and Ma, L and Holland, JF and Bekesi, G. (1998) Anticancer Drug Design, 13, pp. 735-747.
10. Shelanski, ML and Gaskin, F and Cantor, CR. (1973) Proc Natl Acad Sci USA, 70, pp. 765-768.
11. Fellous, A and Francon, J and Lennon, AM and Nunez, J. (1977) Eur J Biochem, 78, pp. 167-174.
12. Weingarten, MD and Lockwood, AH and Hwo, SY and Kirschner, MW. (1975) Proc Natl Acad Sci USA, 72, pp. 1848-1852.
13. Le Pape, P and Zidane, M and Abdala, H and More, MT. (2000) Cell Biology Intern, 24, pp. 51-56.
14. Abdala, H and Robert, JM and Le Pape, P and Wielgosz, G and Robert Piessard, S and Le Baut, G. (2000) Arzneim.-Forsch/Drug Res, 50, pp. 479-484.
15. Le Pape, P and Pagniez, F. (2002) Acta Parasitol, 41, pp. 79-81.
16. Chandrasekaran, EV and Davidson, EA. (1979) Cancer Res, 39, pp. 870-880.
17. Kalil, J and Fellous, A and Fellous, M. (1988) Culture de cellules animales, méthodologies, applications Eds INSERM, 199, pp. 101-130.
18. Croft, SL and Neal, RA and Pendergast, W and Chan, JH. (1987) Biochem Pharmacol, 15, pp. 2633-2636.
19. Jiang, JD and Davis, AS and Middleton, K and Ling, YH and Perez-Soler, R and Holland, JF and Bekesi, JG. (1998) Cancer Res, 58, pp. 5389-5395.
20. Cleveland, DW and Sullivan, KF. (1985) Annu Rev Biochem, 54, pp. 331-365.
21. Joshi, HC and Cleveland, DW. (1990) Cell Motility Cytoskel, 16, pp. 159-163.
22. Luduena, RF. (1998) Int Rev Cytol, 178, pp. 207-275.
23. Banerjee, A and Luduena, RF. (1992) J Biol Chem, 267, pp. 13335-13339.
24. Derry, WB and Wilson, L and Khan, IA and Luduena, RF and Jordan, MA. (1997) Biochemistry, 36, pp. 3554-3562.
25. Laing, N and Dahllöf, B and Hatley-Asp, B and Ranganathan, S and Tew, KD. (1997) Biochemistry, 36, pp. 871-878.
26. Coulson, RMR and Connor, V and Chen, JC and Ajioka, JW. (1996) Mol Biochem Parasitol, 82, pp. 227-236.
27. Fong, D and Wallach, JK and Melera, PW and Chang, KP. (1984) Proc Natl Acad Sci USA, 81, pp. 5782-5786.
28. Chan, MM and Triemer, RE and Fong, D. (1991) Differentiation, 46, pp. 15-21.
29. Luduena, RF and Fellous, A and Mc Manus, L and Jordan, MA and Nunez, J. (1984) J Biol Chem, 259, pp. 12890-12898.
30. Fellous, A and Luduena, RF and Prasad, V and Jurdan, MA and Anderson, W and Ohayon, R and Smith, PT. (1985) Cancer Res, 45, pp. 5004-5010.
31. Fromes, Y and Gounon, P and Tapiero, H and Fellous, A. (1996) J Prot Chem, 15, pp. 561-573.